UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease – Clinical practice recommendations

Parkinsonism & related disorders, 2015-09, Vol.21 (9), p.1023-1030

2015

Volltextzugriff (PDF)

Apomorphine and its esters: Differences in Caco-2 cell permeability and chylomicron affinity

International journal of pharmaceutics, 2016-07, Vol.509 (1-2), p.499-506

2016

Volltextzugriff (PDF)

Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson’s disease complicated by OFF episodes: a phase 3, open-label study

Journal of neurology, 2024-06, Vol.271 (6), p.3554-3570

2024

Volltextzugriff (PDF)

Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study

Parkinsonism & related disorders, 2021-02, Vol.83, p.79-85

2021

Volltextzugriff (PDF)

Effective delivery of apomorphine in the management of Parkinson disease: practical considerations for clinicians and Parkinson nurses

Clinical neuropharmacology, 2015-05, Vol.38 (3), p.89-103

2015

Volltextzugriff (PDF)

Apomorphine - pharmacological properties and clinical trials in Parkinson's disease

Parkinsonism & related disorders, 2016-12, Vol.33, p.S13-S21

2016

Volltextzugriff (PDF)

In vivo evaluation of lipid-based formulations for oral delivery of apomorphine and its diester prodrugs

International journal of pharmaceutics, 2016-11, Vol.513 (1-2), p.211-217

2016

Volltextzugriff (PDF)

A deep eutectic-based, self-emulsifying subcutaneous depot system for apomorphine therapy in Parkinson's disease

Proceedings of the National Academy of Sciences - PNAS, 2022-03, Vol.119 (9), p.1

2022

Volltextzugriff (PDF)

Stylo d’apomorphine dans la maladie de Parkinson : utilisation et défis – résultats d’une étude de pratique dans le réseau NS-Park

Revue neurologique, 2024-04, Vol.180, p.S17-S17

Aubignat, Mickael

2024

Volltextzugriff (PDF)

Synthetic aporphine alkaloids are potential therapeutics for Leigh syndrome

Scientific reports, 2024-05, Vol.14 (1), p.11561-11561, Article 11561

2024

Volltextzugriff (PDF)

Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease

Movement disorders, 2016-09, Vol.31 (9), p.1366-1372

2016

Volltextzugriff (PDF)

Sublingual apomorphine in treatment of Parkinson's disease: a review

International journal of neuroscience, 2024-05, Vol.ahead-of-print (ahead-of-print), p.1-7

2024

Volltextzugriff (PDF)

Prise en charge du patient parkinsonien sous pompe à Apomorphine : rôle du pharmacien d’officine et relations avec les prestataires de santé

Revue neurologique, 2023-04, Vol.179, p.S29-S29

2023

Volltextzugriff (PDF)

Open-label titration of apomorphine sublingual film in patients with Parkinson's disease and “OFF” episodes

Parkinsonism & related disorders, 2020-10, Vol.79, p.110-116

2020

Volltextzugriff (PDF)

On‐Demand Therapy for OFF Episodes in Parkinson's Disease

Movement disorders, 2021-10, Vol.36 (10), p.2244-2253

2021

Volltextzugriff (PDF)

Apomorphine et somnolence diurne excessive dans la maladie de Parkinson : étude DOPAWAKE

Revue neurologique, 2022-04, Vol.178, p.S136-S136

2022

Volltextzugriff (PDF)

Rôle de l’infirmier prestataire et de son partenariat avec le neurologue lors de l’instauration d’une pompe à apomorphine à domicile pour les patients parkinsoniens âgés vivant seuls et sans proche aidant : à propos de trois observations

Revue neurologique, 2022-04, Vol.178, p.S21-S21

2022

Volltextzugriff (PDF)

Description de la dose équivalente de Levodopa (LED) au cours de la mise sous pompe à apomorphine chez le parkinsonien : avant instauration, sortie d’hospitalisation et à distance

Le Pharmacien Clinicien, 2024-06, Vol.59 (2), p.e50-e51

2024

Volltextzugriff (PDF)

The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future

Drugs in R&D, 2018-06, Vol.18 (2), p.91-107

2018

Volltextzugriff (PDF)

Root System Depth in Arabidopsis Is Shaped by EXOCYST70A3 via the Dynamic Modulation of Auxin Transport

Cell, 2019-07, Vol.178 (2), p.400-412.e16

2019

Volltextzugriff (PDF)

Pharmacological Insights into the Use of Apomorphine in Parkinson’s Disease: Clinical Relevance

Clinical drug investigation, 2018-04, Vol.38 (4), p.287-312

2018

Volltextzugriff (PDF)

Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients

Clinical and translational science, 2024-05, Vol.17 (5), p.e13796-n/a

2024

Volltextzugriff (PDF)

LC-MS/MS simultaneous quantification of apomorphine and its major metabolites in human plasma: Application to clinical comparative bioavailability evaluation for the apomorphine sublingual film and a subcutaneous product

Journal of pharmaceutical and biomedical analysis, 2020-10, Vol.190, p.113493, Article 113493

2020

Volltextzugriff (PDF)

Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies

Neurological sciences, 2019-09, Vol.40 (9), p.1917-1923

2019

Volltextzugriff (PDF)

Oral Apomorphine Delivery from Solid Lipid Nanoparticles with Different Monostearate Emulsifiers: Pharmacokinetic and Behavioral Evaluations

Journal of pharmaceutical sciences, 2011-02, Vol.100 (2), p.547-557

2011

Volltextzugriff (PDF)

1 – 25 von 10.184

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(8.732)
Mit Volltextzugriff
(7.567)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Animals
(7.739)
Science & Technology
(7.098)
Life Sciences & Biomedicine
(6.896)
Apomorphine - Pharmacology
(6.528)
Male
(6.347)
Rats
(5.476)
Neurosciences & Neurology
(3.720)
Apomorphine
(3.710)
Biological And Medical Sciences
(3.412)
Pharmacology & Pharmacy
(3.364)
Neurosciences
(3.296)
Humans
(2.908)
Medical Sciences
(2.447)
Female
(1.932)
Motor Activity - Drug Effects
(1.840)
Pharmacology. Drug Treatments
(1.794)
Dopamine
(1.711)
Rats, Inbred Strains
(1.690)
Stereotyped Behavior - Drug Effects
(1.587)
Receptors, Dopamine - Drug Effects
(1.522)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

European Journal Of Pharmacology
(619)
Pharmacology, Biochemistry And Behavior
(533)
Psychopharmacology
(492)
Brain Research
(481)
Psychopharmacologia
(329)
Neuropharmacology
(270)
Life Sciences
(255)
The Journal Of Pharmacology And Experimental Therapeutics
(203)
Behavioural Brain Research
(167)
Journal Of Pharmacy And Pharmacology
(152)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease – Clinical practice recommendations

Apomorphine and its esters: Differences in Caco-2 cell permeability and chylomicron affinity

Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson’s disease complicated by OFF episodes: a phase 3, open-label study

Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study

Effective delivery of apomorphine in the management of Parkinson disease: practical considerations for clinicians and Parkinson nurses

Apomorphine - pharmacological properties and clinical trials in Parkinson's disease

In vivo evaluation of lipid-based formulations for oral delivery of apomorphine and its diester prodrugs

A deep eutectic-based, self-emulsifying subcutaneous depot system for apomorphine therapy in Parkinson's disease

Stylo d’apomorphine dans la maladie de Parkinson : utilisation et défis – résultats d’une étude de pratique dans le réseau NS-Park

Synthetic aporphine alkaloids are potential therapeutics for Leigh syndrome

Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease

Sublingual apomorphine in treatment of Parkinson's disease: a review

Prise en charge du patient parkinsonien sous pompe à Apomorphine : rôle du pharmacien d’officine et relations avec les prestataires de santé

Open-label titration of apomorphine sublingual film in patients with Parkinson's disease and “OFF” episodes

On‐Demand Therapy for OFF Episodes in Parkinson's Disease

Apomorphine et somnolence diurne excessive dans la maladie de Parkinson : étude DOPAWAKE

Rôle de l’infirmier prestataire et de son partenariat avec le neurologue lors de l’instauration d’une pompe à apomorphine à domicile pour les patients parkinsoniens âgés vivant seuls et sans proche aidant : à propos de trois observations

Description de la dose équivalente de Levodopa (LED) au cours de la mise sous pompe à apomorphine chez le parkinsonien : avant instauration, sortie d’hospitalisation et à distance

The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future

Root System Depth in Arabidopsis Is Shaped by EXOCYST70A3 via the Dynamic Modulation of Auxin Transport

Pharmacological Insights into the Use of Apomorphine in Parkinson’s Disease: Clinical Relevance

Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients

LC-MS/MS simultaneous quantification of apomorphine and its major metabolites in human plasma: Application to clinical comparative bioavailability evaluation for the apomorphine sublingual film and a subcutaneous product

Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies

Oral Apomorphine Delivery from Solid Lipid Nanoparticles with Different Monostearate Emulsifiers: Pharmacokinetic and Behavioral Evaluations

Suchergebnisse filtern